[Special Stock] Pharmicell Gains Strength as Remdesivir Special Import Possible...
[Asia Economy Reporter Yoo Hyun-seok] Pamicell is showing strong performance. It appears to be influenced by the quarantine authorities' announcement that Remdesivir can be imported under special provisions.
As of 2:23 PM on the 26th, Pamicell was trading at 23,900 KRW, up 2.14% (500 KRW) compared to the previous trading day.
On the same day, the quarantine authorities announced in a regular briefing that, following discussions by the Central Clinical Committee, special and emergency importation of Remdesivir is planned.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
Pamicell produces 'nucleosides,' the main raw material for Remdesivir. Pamicell holds more than 80% of the global market for diagnostic and pharmaceutical nucleosides.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
